←Back to Expert Scholars
Translational Medicine / 转化医学TIL Therapy, Immunotherapy Trials
Elad Sharon
MD, MPH
🏢National Cancer Institute🌐USA
Senior Investigator, Cancer Therapy Evaluation Program
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Elad Sharon oversees early phase immunotherapy and cell therapy trials at the NCI Cancer Therapy Evaluation Program. He has guided multicenter TIL studies including expansion into non melanoma solid tumors such as lung cancer. His work shapes federal immunotherapy trial priorities.
Share:
🧪Research Fields 研究领域
TIL therapy
CTEP
immunotherapy
NCI trials
lung cancer
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Elad Sharon 的研究动态
Follow Elad Sharon's research updates
留下邮箱，当我们发布与 Elad Sharon（National Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment